12228.00GBP+1.16%Mkt Cap: 240.45B $P/E: 24.47Today
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap240.45B $
Enterprise Value275.69B $
Revenue (TTM)78.71B $
Gross Profit61.70B $
Net Income (TTM)13.11B $
Revenue/Share50.78 USD
Last Price12228.00 GBP
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees96.1K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)24.47
P/E (Forward)14.23
PEG1.41
EV/EBITDA10.80
EV/Revenue3.50
P/S3.02
P/B4.99
EPS (TTM)4.94
EPS (Forward)8.41
52W Range
0.000077% of range15830.00
52W High15830.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin81.90%
Oper. Margin23.46%
EBITDA Margin32.44%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth6.40%
Earnings Growth2.50%
Cash Flow & Leverage
Operating CF18.69B $
CapEx (TTM)7.57B $
FCF Margin7.99%
FCF Yield2.62%
Net Debt35.12B $
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.60
Current Ratio0.89
Quick Ratio0.66
Book Value/Sh23.96 GBP
Cash/Share3.203 GBP
Dividends
Fwd Div Rate2.390 GBP
Trail. Div Rate3.230 GBP
Div. Yield1.98%
5Y Avg Yield2.07%
Payout Ratio47.41%
Ex-Div DateAug 6, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15555.80 GBP
Upside (mean)+27.2%
Target Range11133.47 GBP – 19870.51 GBP
GBP11133.47+27.2% to meanGBP19870.51
# Analysts22
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions65.09%
Technical
SMA 5012916.84 (-5.3%)
SMA 20013810.33 (-11.5%)
Beta0.21
S&P 52W Chg18.16%
Avg Vol (30d)2.91M
Avg Vol (10d)4.02M
Technical Indicators
RSI (14)44.3
MACD-370.7699
MACD Signal-396.8256
MACD Hist.+26.0556
BB Upper13238.09 GBP
BB Middle12237.90 GBP
BB Lower11237.71 GBP
BB Width16.35%
ATR (14)509.42 GBP
Vol Ratio (20d)1.00x